G. Link

发表

Screening for Active Small Molecules in Mitochondrial Complex I Deficient Patient's Fibroblasts, Reveals AICAR as the Most Beneficial Compound

Anna Golubitzky, P. Dan, S. Weissman, 2011, PloS one.

Effects of Amlodipine, Captopril, and Bezafibrate on Oxidative Milieu in Rats with Fatty Liver

G. Link, O. Pappo, Z. Ackerman, 2008, Digestive Diseases and Sciences.

Fructose-Induced Fatty Liver Disease: Hepatic Effects of Blood Pressure and Plasma Triglyceride Reduction

G. Link, O. Pappo, Z. Ackerman, 2005, Hypertension.

ICL670A: a new synthetic oral chelator: evaluation in hypertransfused rats with selective radioiron probes of hepatocellular and reticuloendothelial iron stores and in iron-loaded rat heart cells in culture.

G. Link, W. Breuer, Z. Cabantchik, 2001, Blood.

Effect of hepatic iron concentration reduction on hepatic fibrosis and damage in rats with cholestatic liver disease.

G. Link, O. Pappo, Z. Ackerman, 2006, World journal of gastroenterology.

Liver Toxicity of Thioacetamide is Increased by Hepatocellular Iron Overload

G. Link, O. Pappo, Z. Ackerman, 2014, Biological Trace Element Research.

The synthetic cannabinoid HU-210 attenuates neural damage in diabetic mice and hyperglycemic pheochromocytoma PC12 cells

E. Berry, G. Link, Y. Dagon, 2007, Neurobiology of Disease.

New Directions in Iron Chelating Therapy

G. Link, C. Hershko, 1996 .

Cardioprotective effect of iron chelators.

G. Link, A. Konijn, C. Hershko, 2002, Advances in experimental medicine and biology.

Objectives and Mechanism of Iron Chelation Therapy

Z. Cabantchik, G. Link, Z. Cabantchik, 2005, Annals of the New York Academy of Sciences.

ATP synthesis in lipoamide dehydrogenase deficiency.

G. Link, Ann Saada, O. Elpeleg, 2000, Biochemical and biophysical research communications.

Exploring the "iron shuttle" hypothesis in chelation therapy: effects of combined deferoxamine and deferiprone treatment in hypertransfused rats with labeled iron stores and in iron-loaded rat heart cells in culture.

G. Link, W. Breuer, Z. Cabantchik, 2001, The Journal of laboratory and clinical medicine.

Pathophysiology of Iron Overload a

G. Link, I. Cabantchik, C. Hershko, 1998, Annals of the New York Academy of Sciences.

Iron Chelators for Thalassaemia

G. Link, A. Konijn, C. Hershko, 1998, British journal of haematology.

Iron overload and chelation

G. Link, A. Konijn, C. Hershko, 2005, Hematology.

Action of chelators in iron-loaded cardiac cells: Accessibility to intracellular labile iron and functional consequences.

G. Link, W. Breuer, Z. Cabantchik, 2006, Blood.

Effects of Combined Chelation Treatment with Pyridoxal Isonicotinoyl Hydrazone (PIH) Analogs and Deferoxamine in Hypertransfused Rats and in Iron-Loaded Rat Heart Cells Running Head: Combined PIH analog and DFO Chelation Treatment Heading: Red Cells

G. Link, P. Ponka, W. Breuer, 2017 .

Effects of combined chelation treatment with pyridoxal isonicotinoyl hydrazone analogs and deferoxamine in hypertransfused rats and in iron-loaded rat heart cells.

Z. Cabantchik, G. Link, P. Ponka, 2003, Blood.

Iron Chelation Therapy

G. Link, Z. Cabantchik, A. Konijn, 2002, Advances in Experimental Medicine and Biology.

labile iron and functional consequences Action of chelators in iron-loaded cardiac cells : accessibility to intracellular

G. Link, W. Breuer, Z. Cabantchik, 2006 .

Therapeutic Potential of Iron Chelating Therapy: Modification of Disease by Iron Depletion

G. Link, C. Hershko, A. Pinson, 1994, Metal-based drugs.

Iron-chelator complexes as iron sources for early developing human erythroid precursors.

G. Link, E. Fibach, A. Konijn, 2008, Translational research : the journal of laboratory and clinical medicine.

IRC011, a new synthetic chelator with selective interaction with catabolic red blood cell iron: evaluation in hypertransfused rats with hepatocellular and reticuloendothelial radioiron probes and in iron-loaded rat heart cells in culture.

G. Link, G. Rivkin, R. Cyjon, 1997, Blood.

Evaluation of iron‐chelating agents in an in vivo system: potential usefulness of EHPG, a powerful iron‐chelating drug

G. Link, R. Grady, C. Hershko, 1982, British journal of haematology.

The Effects of Chronic Iron Overload in Rats with Acute Acetaminophen Overdose

G. Link, O. Pappo, Z. Ackerman, 2018, Toxicologic pathology.

Liver Toxicity of Thioacetamide is Increased by Hepatocellular Iron Overload

G. Link, O. Pappo, Z. Ackerman, 2015, Biological Trace Element Research.

Diagnostic value of ferritin in malignant pleural and peritoneal effusions

A. Yinnon, G. Link, A. Konijn, 1988, Cancer.

Role of iron in the potentiation of anthracycline cardiotoxicity: identification of heart cell mitochondria as a major site of iron-anthracycline interaction.

G. Link, C. Hershko, A. Pinson, 1996, The Journal of laboratory and clinical medicine.

Cardioprotective effect of alpha-tocopherol, ascorbate, deferoxamine, and deferiprone: mitochondrial function in cultured, iron-loaded heart cells.

G. Link, A. Konijn, C. Hershko, 1999, The Journal of laboratory and clinical medicine.

Iron loading modifies the fatty acid composition of cultured rat myocardial cells and liposomal vesicles: effect of ascorbate and alpha-tocopherol on myocardial lipid peroxidation.

G. Link, C. Hershko, A. Pinson, 1989, The Journal of laboratory and clinical medicine.

Mitochondrial respiratory enzymes are a major target of iron toxicity in rat heart cells.

G. Link, Ann Saada, A. Konijn, 1998, The Journal of laboratory and clinical medicine.

The role of iron and iron chelators in anthracycline cardiotoxicity.

G. Link, C. Hershko, A. Pinson, 1993, Leukemia & lymphoma.